Showing results (41-50 of 154) with videos related to
Sort By:
Pageof 16
Annales Academiae Medicae Stetinensis|March 4, 2011
[Wegener's granulomatosis with subglottic stenosis: options for local and systemic treatment. Review of the literature]Bozena Targońska-Stepniak, Maria MajdanMediators of Inflammation|December 20, 2014
Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritisBożena Targońska-Stępniak, Maria MajdanPolskie Archiwum Medycyny Wewnetrznej|May 3, 2011
Associations between parameters of nutritional status and disease activity in patients with rheumatoid arthritisBożena Targońska-Stępniak, Maria MajdanPostepy Higieny I Medycyny Doswiadczalnej (Online)|July 5, 2005
[The musculoskeletal system in diabetic patients]Jolanta Parada-Turska, Maria MajdanClinical Rheumatology|May 14, 2009
Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanReumatologia|June 1, 2022
Methods of assessment of joint involvement in various systemic connective tissue diseasesTobiasz Kardas, Ewa Wielosz, Maria MajdanPostepy Dermatologii I Alergologii|February 19, 2021
Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanWiadomosci Lekarskie (Warsaw, Poland : 1960)|March 21, 2018
[Epigenetic disturbances in systemic lupus erythematosus]Magdalena Dryglewska, Bogdan Kolarz, Maria MajdanPostepy Higieny I Medycyny Doswiadczalnej (Online)|September 18, 2014
Serological profile of patients with systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanAnnals of Agricultural and Environmental Medicine : AAEM|March 29, 2021
The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosisEwa Wielosz, Magdalena Dryglewska, Maria MajdanPageof 16